India, Sept. 28 -- NeOnc Technologies Holdings, Inc. (NTHI) announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on November 17, 2026, for an in-person End-of-Phase ... Read More
India, Sept. 28 -- Chugai Pharmaceutical Co., Ltd. (4519) announced that development of Emugrobart (GYM329) for obesity has been discontinued, with all rights to the drug being returned by Roche (RHHB... Read More
India, Sept. 28 -- Swiss pharmaceutical Roche Holding AG (RHHBY) outlined plans on Monday to develop autonomous AI-driven laboratories as part of its efforts to accelerate research and development and... Read More
India, Sept. 28 -- On Monday, HCL Technologies Ltd. (HCLTECH.BO), an Indian IT company, announced that its subsidiary, HCLSoftware is planning to acquire Robotic.ai, a provider of Enterprise Robotic P... Read More
India, Sept. 28 -- Akeso, Inc. (9926.HK), a biopharmaceutical company, announced that it has enrolled the first patient in COMPASSION-37 (AK104-311), a phase 3 trial evaluating Cadonilimab as first-li... Read More
India, Sept. 28 -- Monday, OSI Systems Inc (OSIS), a specialized electronic systems manufacturer, announced that its Optoelectronics and Manufacturing division has received orders of approximately $7 ... Read More
India, Sept. 28 -- Citigroup Inc. (C) announced on Monday that it has expanded its collaboration with Coinbase (COIN) to connect traditional banking with digital asset payments for corporations and co... Read More
India, Sept. 28 -- Silexion Therapeutics Corp. (SLXN) announced positive findings from an ongoing translational study evaluating the cellular uptake and gene-silencing mechanism of SIL204, its lead RN... Read More
India, Sept. 28 -- Indian shares were deep in the red on Monday after U.S. President Donald Trump rejected Iran's latest proposal to reopen the Strait of Hormuz and other demands. It was reported tha... Read More
India, Sept. 28 -- Oncolytics Biotech, Inc. (ONCY) announced continued clinical and operational progress in REO 033, a randomized study evaluating pelareorep in combination with FOLFIRI and bevacizuma... Read More